Phenotype and tissue expression as a function of genetic risk in polycystic ovary syndrome

PLoS ONE

Volumn 12, Issue 1, 2017, Pages

  Pau, Cindy T ^a   Mosbruger, Tim ^b   Saxena, Richa ^a   Welt, Corrine K ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LUTEINIZING HORMONE; METFORMIN; RNA; TRANSCRIPTION FACTOR GATA 4; BIOLOGICAL MARKER; FOLLITROPIN;

ARTICLE; BIOPSY; BLK GENE; CLINICAL ARTICLE; DRUG RESPONSE; ERBB4 GENE; EUROPEAN; FHSR GENE; FSHB GENE; GATA4 GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GLIPR1 GENE; HUMAN; HUMAN TISSUE; HYPERANDROGENISM; IRF1 GENE; KRR1 GENE; LHR GENE; LUTEINIZING HORMONE BLOOD LEVEL; NEIL2 GENE; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PHLDA1 GENE; QUANTITATIVE TRAIT LOCUS; RAB5B GENE; RNA SEQUENCE; SUBCUTANEOUS FAT; SUMO1P1 GENE; THADA GENE; WOMEN'S HEALTH; ANTIBODY SPECIFICITY; CASE CONTROL STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; POLYCYSTIC OVARY SYNDROME; SIGNAL TRANSDUCTION;

BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; FOLLICLE STIMULATING HORMONE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUTEINIZING HORMONE; METFORMIN; ORGAN SPECIFICITY; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; QUANTITATIVE TRAIT LOCI; SIGNAL TRANSDUCTION;

EID: 85009114635     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0168870     Document Type: Article

References (40)

1. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19:41-47 PMID: 14688154
2. Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endo Rev 1995; 16:322-353
3. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999; 22:141-146 PMID: 10333916
4. Vink JM, Sadrzadeh S, Lambalk CB, Boomsma DI. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab 2006; 91:2100-2104 doi: 10.1210/jc.2005-1494 PMID: 16219714
5. Shi Y, Zhao H, Shi Y, Cao Y, Yang D, Li Z, Zhang B, Liang X, Li T, Chen J, Shen J, Zhao J, You L, Gao X, Zhu D, Zhao X, Yan Y, Qin Y, Li W, Yan J, Wang Q, Zhao J, Geng L, Ma J, Zhao Y, He G, Zhang A, Zou S, Yang A, Liu J, Li W, Li B, Wan C, Qin Y, Shi J, Yang J, Jiang H, Xu JE, Qi X, Sun Y, Zhang Y, Hao C, Ju X, Zhao D, Ren CE, Li X, Zhang W, Zhang Y, Zhang J, Wu D, Zhang C, He L, Chen ZJ. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet 2012; 44:1020-1025 doi: 10.1038/ng.2384 PMID: 22885925
6. Chen ZJ, Zhao H, He L, Shi Y, Qin Y, Shi Y, Li Z, You L, Zhao J, Liu J, Liang X, Zhao X, Zhao J, Sun Y, Zhang B, Jiang H, Zhao D, Bian Y, Gao X, Geng L, Li Y, Zhu D, Sun X, Xu JE, Hao C, Ren CE, Zhang Y, Chen S, Zhang W, Yang A, Yan J, Li Y, Ma J, Zhao Y. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet 2011; 43:55-59 doi: 10.1038/ng.732 PMID: 21151128
7. Day FR, Hinds DA, Tung JY, Stolk L, Styrkarsdottir U, Saxena R, Bjonnes A, Broer L, Dunger DB, Halldorsson BV, Lawlor DA, Laval G, Mathieson I, McCardle WL, Louwers Y, Meun C, Ring S, Scott RA, Sulem P, Uitterlinden AG, Wareham NJ, Thorsteinsdottir U, Welt C, Stefansson K, Laven JS, Ong KK, Perry JR. Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. Nat Commun 2015; 6:8464 doi: 10.1038/ncomms9464 PMID: 26416764
8. Meun CK, T.; Magi, R.; Drong, A.W.; Armstrong, L.; Broer, L.; Jones, M.R.; Day, F.R.; PCOS Genetics Consortium. Program #933: Genome-wide meta-analysis of polycystic ovary syndrome in women of European ancestry identifies new loci in hormone pathways. Presented at the 65th Annual meeting of the American Society of Human Genetics October 7, 2015; Baltimore, MD
9. Hayes MG, Urbanek M, Ehrmann DA, Armstrong LL, Lee JY, Sisk R, Karaderi T, Barber TM, McCarthy MI, Franks S, Lindgren CM, Welt CK, Diamanti-Kandarakis E, Panidis D, Goodarzi MO, Azziz R, Zhang Y, James RG, Olivier M, Kissebah AH, Reproductive Medicine N, Stener-Victorin E, Legro RS, Dunaif A. Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat Commun 2015; 6:7502 doi: 10.1038/ncomms8502 PMID: 26284813
10. Welt CK, Styrkarsdottir U, Ehrmann DA, Thorleifsson G, Arason G, Gudmundsson JA, Ober C, Rosenfield RL, Saxena R, Thorsteinsdottir U, Crowley WF, Stefansson K. Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry. J Clin Endocrinol Metab 2012; 97:E1342-1347 doi: 10.1210/jc.2011-3478 PMID: 22547425
11. van de Bunt M, Manning Fox JE, Dai X, Barrett A, Grey C, Li L, Bennett AJ, Johnson PR, Rajotte RV, Gaulton KJ, Dermitzakis ET, MacDonald PE, McCarthy MI, Gloyn AL. Transcript Expression Data from Human Islets Links Regulatory Signals from Genome-Wide Association Studies for Type 2 Diabetes and Glycemic Traits to Their Downstream Effectors. PLoS Genet 2015; 11:e1005694 doi: 10.1371/journal.pgen.1005694 PMID: 26624892
12. Grundberg E, Small KS, Hedman AK, Nica AC, Buil A, Keildson S, Bell JT, Yang TP, Meduri E, Barrett A, Nisbett J, Sekowska M, Wilk A, Shin SY, Glass D, Travers M, Min JL, Ring S, Ho K, Thorleifsson G, Kong A, Thorsteindottir U, Ainali C, Dimas AS, Hassanali N, Ingle C, Knowles D, Krestyaninova M, Lowe CE, Di Meglio P, Montgomery SB, Parts L, Potter S, Surdulescu G, Tsaprouni L, Tsoka S, Bataille V, Durbin R, Nestle FO, O'Rahilly S, Soranzo N, Lindgren CM, Zondervan KT, Ahmadi KR, Schadt EE, Stefansson K, Smith GD, McCarthy MI, Deloukas P, Dermitzakis ET, Spector TD, Multiple Tissue Human Expression Resource C. Mapping cis- and trans-regulatory effects across multiple tissues in twins. Nat Genet 2012; 44:1084-1089 doi: 10.1038/ng.2394 PMID: 22941192
13. Small KS, Hedman AK, Grundberg E, Nica AC, Thorleifsson G, Kong A, Thorsteindottir U, Shin SY, Richards HB, Consortium G, Investigators M, Consortium D, Soranzo N, Ahmadi KR, Lindgren CM, Stefansson K, Dermitzakis ET, Deloukas P, Spector TD, McCarthy MI, Mu TC. Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes. Nat Genet 2011; 43:561-564 doi: 10.1038/ng.833 PMID: 21572415
14. Fairfax BP, Humburg P, Makino S, Naranbhai V, Wong D, Lau E, Jostins L, Plant K, Andrews R, McGee C, Knight JC. Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science 2014; 343:1246949 doi: 10.1126/science.1246949 PMID: 24604202
15. Saxena R, Bjonnes AC, Georgopoulos NA, Koika V, Panidis D, Welt CK. Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume. Hum Reprod 2015; 30:1697-1703 doi: 10.1093/humrep/dev110 PMID: 25994816
16. Saxena R, Bjonnes AC, Georgopoulos NA, Koika V, Panidis D, Welt CK. Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume. Human reproduction. 2015; 30(7):1697-703. doi: 10.1093/humrep/dev110 PMID: 25994816
17. Ruth KS, Campbell PJ, Chew S, Lim EM, Hadlow N, Stuckey BG, Brown SJ, Feenstra B, Joseph J, Surdulescu GL, Zheng HF, Richards JB, Murray A, Spector TD, Wilson SG, Perry JR. Genome-wide association study with 1000 genomes imputation identifies signals for nine sex hormone-related phenotypes. Eur J Hum Genet 2015;
18. Abel MH, Widen A, Wang X, Huhtaniemi I, Pakarinen P, Kumar TR, Christian HC. Pituitary Gonadotrophic Hormone Synthesis, Secretion, Subunit Gene Expression and Cell Structure in Normal and Follicle-Stimulating Hormone beta Knockout, Follicle-Stimulating Hormone Receptor Knockout, Luteinising Hormone Receptor Knockout, Hypogonadal and Ovariectomised Female Mice. J Neuroendocrinol 2014; 26:785-795 doi: 10.1111/jne.12178 PMID: 25039914
19. Fortin J, Boehm U, Deng CX, Treier M, Bernard DJ. Follicle-stimulating hormone synthesis and fertility depend on SMAD4 and FOXL2. FASEB J 2014; 28:3396-3410 doi: 10.1096/fj.14-249532 PMID: 24739304
20. Luftner D, Jung A, Schmid P, Geppert R, Kienle E, Wernecke KD, Possinger K, Takeda Adjuvant Breast Cancer Study with Leuprorelin Study G. Upregulation of HER-2/neu by ovarian ablation: results of a randomized trial comparing leuprorelin to CMF as adjuvant therapy in node-positive breast cancer patients. Breast Cancer Res Treat 2003; 80:245-255 PMID: 14503797
21. Goodarzi MO, Jones MR, Li X, Chua AK, Garcia OA, Chen YD, Krauss RM, Rotter JI, Ankener W, Legro RS, Azziz R, Strauss JF 3rd, Dunaif A, Urbanek M. Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. J Med Genet 2012; 49:90-95 doi: 10.1136/jmedgenet-2011-100427 PMID: 22180642
22. Pau CT, Keefe C, Duran J, Welt CK. Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study. J Clin Endocrinol Metab 2014; 99:1870-1878 doi: 10.1210/jc.2013-4021 PMID: 24606093
23. Simonis-Bik AM, Nijpels G, van Haeften TW, Houwing-Duistermaat JJ, Boomsma DI, Reiling E, van Hove EC, Diamant M, Kramer MH, Heine RJ, Maassen JA, Slagboom PE, Willemsen G, Dekker JM, Eekhoff EM, de Geus EJ, Hart LM. Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function. Diabetes 2010; 59:293-301 doi: 10.2337/db09-1048 PMID: 19833888
24. Borowiec M, Liew CW, Thompson R, Boonyasrisawat W, Hu J, Mlynarski WM, El Khattabi I, Kim SH, Marselli L, Rich SS, Krolewski AS, Bonner-Weir S, Sharma A, Sale M, Mychaleckyj JC, Kulkarni RN, Doria A. Mutations at the BLK locus linked to maturity onset diabetes of the young and beta-cell dysfunction. PNAS 2009; 106:14460-14465 doi: 10.1073/pnas.0906474106 PMID: 19667185
25. Chakraborty A, Wakamiya M, Venkova-Canova T, Pandita RK, Aguilera-Aguirre L, Sarker AH, Singh DK, Hosoki K, Wood TG, Sharma G, Cardenas V, Sarkar PS, Sur S, Pandita TK, Boldogh I, Hazra TK. Neil2-null Mice Accumulate Oxidized DNA Bases in the Transcriptionally Active Sequences of the Genome and Are Susceptible to Innate Inflammation. J Biol Chem 2015; 290:24636-24648 doi: 10. 1074/jbc.M115.658146 PMID: 26245904
26. Toyoshima Y, Karas M, Yakar S, Dupont J, Lee H, LeRoith D. TDAG51 mediates the effects of insulinlike growth factor I (IGF-I) on cell survival. J Biol Chem 2004; 279:25898-25904 doi: 10.1074/jbc. M400661200 PMID: 15037619
27. Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC. The insulin-related ovarian regulatory system in health and disease. Endo Rev 1999; 20:535-582
28. Gibbs GM, Lo JC, Nixon B, Jamsai D, O'Connor AE, Rijal S, Sanchez-Partida LG, Hearn MT, Bianco DM, O'Bryan MK. Glioma pathogenesis-related 1-like 1 is testis enriched, dynamically modified, and redistributed during male germ cell maturation and has a potential role in sperm-oocyte binding. Endocrinology 2010; 151:2331-2342 doi: 10.1210/en.2009-1255 PMID: 20219979
29. Thackray VG, Mellon PL, Coss D. Hormones in synergy: regulation of the pituitary gonadotropin genes. Mol Cell Endocrinol 2010; 314:192-203 doi: 10.1016/j.mce.2009.09.003 PMID: 19747958
30. Raja-Khan N, Urbanek M, Rodgers RJ, Legro RS. The role of TGF-beta in polycystic ovary syndrome. Reprod Sciences 2014; 21:20-31
31. Jones MR, Brower MA, Xu N, Cui J, Mengesha E, Chen YD, Taylor KD, Azziz R, Goodarzi MO. Systems Genetics Reveals the Functional Context of PCOS Loci and Identifies Genetic and Molecular Mechanisms of Disease Heterogeneity. PLoS Genet 2015; 11:e1005455 doi: 10.1371/journal.pgen. 1005455 PMID: 26305227
32. Bhatt S, Mutharasan P, Garcia OA, Jafari N, Legro RS, Dunaif A, Urbanek M. The inflammatory gene pathway is not a major contributor to polycystic ovary snydrome. J Clin Endocrinol Metab 2014; 99: E567-571 doi: 10.1210/jc.2013-2342 PMID: 24423322
33. Carmina E, Chu MC, Moran C, Tortoriello D, Vardhana P, Tena G, Preciado R, Lobo R. Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome. Fertil Steril 2008; 89:642-648 doi: 10.1016/j.fertnstert.2007.03.085 PMID: 17562334
34. Martinez-Garcia MA, Montes-Nieto R, Fernandez-Duran E, Insenser M, Luque-Ramirez M, Escobar-Morreale HF. Evidence for masculinization of adipokine gene expression in visceral and subcutaneous adipose tissue of obese women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 2013; 98:E388-396 doi: 10.1210/jc.2012-3414 PMID: 23337724
35. Manneras-Holm L, Leonhardt H, Kullberg J, Jennische E, Oden A, Holm G, et al. Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. The Journal of clinical endocrinology and metabolism. 2011; 96:E304-11 doi: 10.1210/jc.2010-1290 PMID: 21084397
36. Welt CK, Gudmundsson JA, Arason G, Adams J, Palsdottir H, Gudlaugsdottir G, et al. Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. The Journal of clinical endocrinology and metabolism. 2006; 91:4842-8 doi: 10.1210/jc.2006-1327 PMID: 17003085
37. Welt CK, Arason G, Gudmundsson JA, Adams J, Palsdottir H, Gudlaugsdottir G, et al. Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations. The Journal of clinical endocrinology and metabolism. 2006; 91:4361-8 doi: 10.1210/jc.2006-1191 PMID: 16940441
38. Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D, et al. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. The Journal of clinical endocrinology and metabolism. 1997; 82:2248-56 doi: 10.1210/jcem.82.7.4105 PMID: 9215302
39. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005; 21:263-5 doi: 10.1093/bioinformatics/bth457 PMID: 15297300
40. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15:550 doi: 10.1186/s13059-014-0550-8 PMID: 25516281